Rob Kent, Esq. writes from nearly 20 years of work in state and federal drug policy, including his time as general counsel at the New York State Office of Addiction Services and Supports. In this Harm Reduction Series article, he explains how witnessing preventable loss changed his view of harm reduction and strengthened his belief in the full continuum of care. His central question is direct: how can we help people stay alive and get better?

Joshua Bennett-Johnson argues for harm reduction, naloxone, syringe services, safer-use tools, autonomy, and dignity in addiction care.

Harm reduction is not permission to use. It is a practical plan to keep people alive long enough to have choices. John Makohen offers a direct, compassionate guide to building an overdose safety plan before the most dangerous moment arrives. He covers naloxone, fentanyl risk, reduced tolerance after a break, using a safety buddy, avoiding substance mixing, choosing a safer space, using clean supplies, and writing the plan down so people know what to do under stress.

Therapist Joshua Bennett-Johnson gives a critical breakdown of xylazine’s rise in the drug supply, its deadly interaction with fentanyl, and why traditional overdose response is no longer enough. Essential reading for clinicians and communities.

A clear, compassionate explanation of harm reduction and why meeting people where they are saves lives and builds pathways to recovery.

Post-incarceration syndrome is widely recognized in practice as trauma—often with high overdose risk after release. Sandy Rivers shows how peer support can create continuity of care, reduce recidivism, and strengthen reintegration for individuals and families.

Content Warning: This article discusses opioids, overdoses, and substance-related harms. Nitazenes are a highly potent class of synthetic opioids often mixed—unknown to users— into other drugs. They pose extreme overdose risk, can be difficult to detect on standard tests, and may require multiple naloxone doses. With commentary from Subject Matter Expert Arun Gupta, MD

Critics continue to question substance use harm reduction. Advocates persist in fighting for it. But the data is precise: harm reduction saves lives. As patterns of drug use shift and risks increase, strategies such as overdose prevention centers, fentanyl test strips, and naloxone access offer a proven path forward. This isn't theory; it's survival.

Every year on August 31, people worldwide come together for a cause that is painfully personal to many—International Overdose Awareness Day (IOAD). This day is more than just a date on the calendar; it's a powerful movement. It's an opportunity to grieve, remember, educate, and, most importantly, spark change.